MyFinsight
Home
Blog
About
Contact
Download
Download image
Unrealized gain on
marketable securities
$65K
(-90.95%↓ Y/Y)
Total comprehensive
loss
-$36,700K
(-50.07%↓ Y/Y)
Total other
comprehensive income
$65K
(-90.95%↓ Y/Y)
Interest and investment
income
$3,658K
Gain on investment in
former related party
$227K
Net loss
-$36,765K
(-46.04%↓ Y/Y)
Total other income
$3,523K
(-25.45%↓ Y/Y)
Nonrelated Party
$396K
Other
(expense)/income
-$360K
(-1736.36%↓ Y/Y)
Loss on currency
exchange, net
-$2K
(95.83%↑ Y/Y)
Loss from operations
-$40,288K
(-34.74%↓ Y/Y)
Total revenues
$396K
(-81.77%↓ Y/Y)
Total operating
expenses
$40,684K
(26.85%↑ Y/Y)
Research and development
$32,489K
(27.19%↑ Y/Y)
General and
administrative
$8,195K
(25.54%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Dianthus Therapeutics, Inc. DE (DNTH)
Dianthus Therapeutics, Inc. DE (DNTH)